FDA Grants Breakthrough Status to SonoClear for Intracranial Ultrasound
Designed to reduce imaging artifacts during neurosurgery, the SonoClear System now has FDA Breakthrough Device status and is moving toward 510(k) submission.
Designed to reduce imaging artifacts during neurosurgery, the SonoClear System now has FDA Breakthrough Device status and is moving toward 510(k) submission.
The FDA will expand generative AI tools across all centers by June 30 following a successful scientific review pilot, aiming to reduce repetitive tasks and improve operational efficiency.
In a blind review, scans performed by novices using the software met diagnostic standards and matched expert-level quality.
Designed to reduce imaging artifacts during neurosurgery, the SonoClear System now has FDA Breakthrough Device status and is moving toward 510(k) submission.
The FDA determined that the company has submitted copied, falsified, or otherwise invalid data in submissions to the agency.
Read MoreThe FDA has issued an early alert regarding Baxter’s recall of certain Spectrum infusion pumps due to missing motor mounting screws, which may have occurred during servicing.
Read MoreWhile cybersecurity alerts raised concerns about a potential backdoor linked to a Chinese IP address, researchers uncovered a different—but still serious—security risk.
Read MoreGE HealthCare’s newly FDA-cleared Voluson Expert ultrasound systems integrate AI automation and the Lyric Architecture for enhanced imaging.
Read MoreFresenius Kabi advises updating Ivenix Infusion System software to avoid two anomalies risking under- or over-infusion.
Read MoreThe FDA warned of a shortage of pediatric medical devices and urged Congress to bolster its ability to track and anticipate these issues.
Read MoreFDA has recognized four AAMI sterilization documents in its Consensus Standards Database, including updated guidance on ethylene oxide usage.